Caladrius Takes Former Baxalta Angina Program Off Shire's Hands

Anatomy of Human Heart
Shire licenses angina cell therapy to Caladrius
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business